Oruka Therapeutics Inc (NASDAQ:ORKA) price on Thursday, July 03, fall -0.08% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $12.6.
A look at the stock’s price movement, the close in the last trading session was $12.61, moving within a range at $12.1 and $12.925. Turning to its 52-week performance, $33.00 and $5.49 were the 52-week high and 52-week low respectively. Overall, ORKA moved 5.53% over the past month.
Oruka Therapeutics Inc’s market cap currently stands at around $471.75 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ORKA is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
ORKA’s current price about 4.21% and 13.23% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.24, while 7-day volatility ratio is 8.48% and 7.25% in the 30-day chart. Further, Oruka Therapeutics Inc (ORKA) has a beta value of -0.37. Analysts have given the company’s stock an average 52-week price target of $20, forecast between a low of $20 and high of $20. Looking at the price targets, the low is -58.73% off current price level while to achieve the yearly target high, price needs to move -58.73%. Nonetheless, investors will most likely welcome a -58.73% jump to $20 which is the analysts’ median price.
If we refocus on Oruka Therapeutics Inc (NASDAQ:ORKA), historical trading data shows that trading volumes averaged 0.53 over the past 10 days and 267.82K over the past 3 months. The company’s latest data on shares outstanding shows there are 37.44 million shares.
The 17.46% of Oruka Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 72.79% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.8 million on 2025-06-13, giving us a short ratio of 18.68. The data shows that as of 2025-06-13 short interest in Oruka Therapeutics Inc (ORKA) stood at 1197.9999400000002 of shares outstanding, with shares short rising to 2.72 million registered in 2025-05-15. Current price change has pushed the stock -48.62% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ORKA stock continues to rise going into the next quarter.
